BPF® 20 brings authentic Calabrian bergamot into the formula with a clearly defined phytochemical profile and a practical inclusion level. Derived from bergamot fruit juice, it combines a broad 40% polyphenol fraction with the five characteristic flavanones that define the BPF® platform, making it a versatile botanical for cardiovascular, lipid and metabolic product concepts.
BPF® 20 combines a defined phytochemical specification with access to the broader scientific foundation of the BPF® platform. Standardized to 40% total polyphenols and ≥20% combined flavanones, it provides predictable flavanone delivery across different inclusion levels. Human research across the wider BPF® platform provides additional context in lipid, glucose, vascular, liver and metabolic health, with the specific preparation and dose varying by study.
BPF® 20 is standardized to 40% total polyphenols and ≥20% combined flavanones, providing two distinct measures of its phytochemical composition. The flavanone specification represents the combined concentration of neoeriocitrin, naringin, neohesperidin, melitidin and brutieridin and is verified by HPLC-UV analysis.
Why it matters: Two defined specifications give formulators more compositional detail than a total-polyphenol percentage alone.
Because BPF® 20 is standardized to at least 20% combined flavanones, its minimum flavanone contribution can be calculated directly from the ingredient inclusion level. At specification, 500 mg delivers ≥100 mg, while 1,300 mg delivers ≥260 mg combined flavanones. Actual content may be higher depending on the individual lot assay.
Why it matters: The 20% specification makes active-flavanone delivery easy to calculate around serving size and formula design.
Human research across the broader BPF® platform has evaluated multiple areas of cardiometabolic physiology, including cholesterol and triglycerides, glucose metabolism, lipoprotein characteristics, liver-related markers, endothelial function, nitric oxide and exercise physiology. Individual studies used different BPF® preparations, doses and study populations.
Why it matters: BPF® 20 comes from a research-established ingredient platform, while substantiation can be matched to the specific preparation and dose used in each study.
Research note: BPF® 20 shares the characteristic phytochemical profile of the broader BPF® platform. Published BPF® studies have used different ingredient preparations, standardizations, doses and study populations. Research shown as broader BPF® context should not be interpreted as direct clinical evidence for BPF® 20 unless the specific preparation is identified in the publication.
BPF® 20 is well suited to formulas that approach cardiovascular and metabolic health as connected systems. Its standardized bergamot polyphenol profile provides a natural fit across lipid health, glucose metabolism, vascular wellness and antioxidant protection.
BPF® 20 turns a broad “bergamot extract” declaration into a defined raw-material specification. Its botanical source, fruit fraction, polyphenol content and characteristic flavanones are all identified, giving formulators a more precise and traceable bergamot ingredient.
BPF® 20 is positioned as a versatile standardized bergamot ingredient for foundational cardiovascular and metabolic wellness products. Healthy cholesterol and lipid metabolism provide the clearest lead story, supported by the broader BPF® research heritage, while glucose metabolism, vascular health and antioxidant protection provide relevant secondary territory.
Its breadth makes BPF® 20 especially suitable for everyday heart-health and metabolic formulas where bergamot serves as a central botanical rather than a narrowly positioned single-benefit active.
BPF® 20 is a standardized fruit-juice extract of authentic Citrus bergamia Risso et Poiteau grown in Calabria, Italy. It provides 40% total polyphenols and ≥20% combined flavanones, including the five characteristic flavanones associated with the BPF® platform.
It means neoeriocitrin, naringin, neohesperidin, melitidin and brutieridin collectively account for at least 20% of the ingredient according to specification. At that minimum standardization, 1,000 mg of BPF® 20 provides at least 200 mg of combined flavanones.
BPF® 20 is part of the broader BPF® research platform, which has been investigated in human studies across lipid metabolism, glucose, vascular function and other metabolic parameters. Individual publications have used different BPF® preparations and dosages, so clinical substantiation should be matched to the specific study being referenced.
BPF® 20 can be evaluated for capsules, tablets, powder blends, sachets, stick packs and other dry nutritional formats. It is partially soluble in water at 40°C, so aqueous systems should be evaluated for dispersion, sedimentation, flavor and finished-product stability during development.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us